T.E. Lockhart, R. Soangra, H. Yoon
9 min
Artificial intelligence (AI) is rapidly evolving from a conceptual research interest into a tangible component of orthopaedic trauma care. This overview, drawing from the Orthopaedic Trauma Association (OTA) 2025 Basic Science Focus Forum, outlines how AI can address persistent clinical challenges—specifically through objective fall risk assessment, automated radiographic analysis, and advanced computational simulations.
The authors highlight three primary domains where AI integration is showing promise:
Fall Prevention: By utilizing inertial measurement units (IMUs) and wearable sensors, researchers can now capture complex gait patterns to predict fall risk in elderly populations with high accuracy. This shift toward time-series analysis allows for proactive, personalized interventions before injuries occur.
Diagnostic Efficiency: AI segmentation models, such as adapted U-Net architectures, can automate labor-intensive radiographic measurements like tip-apex distance. These tools have demonstrated agreement with human experts while drastically reducing the time required for post-surgical assessment.
In Silico Trials: AI provides a mechanism to bridge the gap between expensive physics-based simulations and clinical utility. By creating 'surrogate models' trained on virtual patient cohorts, researchers can rapidly predict the impact of different surgical approaches or implant designs, potentially streamlining the testing of new devices without initial human exposure.
The OTA has established a dedicated AI Task Force to guide this integration responsibly. Their strategy focuses on three pillars: establishing ethical guidelines through a formal position statement, managing high-quality data through platforms like the National Trauma Research Repository (NTRR), and creating 'AI playgrounds' where academic and industry partners can safely validate and demonstrate models. The overarching theme is that while AI offers immense potential for objectivity and speed, its successful implementation relies on multidisciplinary teams—pairing data scientists with surgeons to ensure that models remain clinically relevant, equitable, and transparent.
Artificial Intelligence (AI) is an ascendant technical field with potential to revolutionize health care and orthopaedics. This paper highlights ways in which AI is already affecting members of the Orthopaedic Trauma Association (OTA), while identifying paths to clinical application, as presented at the 2025 OTA Annual Meeting's Basic Science Focus Forum. A report from the OTA AI Task Force shared some initial accomplishments, including the crafting of a position statement. Areas of AI application in orthopaedic trauma were discussed, including the prediction of fall risk in the elderly, capabilities for automated image-based diagnosis and outcome assessment, and efforts toward creating a framework for in silico clinical trials that rely upon virtual patient cohorts. Together these applications show how AI is emerging as a foundational tool in orthopaedic trauma research. Over the next few years, these products will be moving from the research laboratory to the clinic. For the tools to be of greatest benefit, a measured development approach using teams of data scientists partnered with orthopaedic trauma surgeons must be adopted. Academia and Industry are both progressing in this direction-the best path forward will likely involve shared development efforts. As these efforts progress, OTA members will undoubtedly be involved. Both they and their patients stand to be the primary beneficiaries of many of these developments.
Sam: They tracked falls over the following six months. The model used features describing variability, complexity, and smoothness of walking. In a blind test, its best version classified fallers and non-fallers with roughly four-in-five accuracy.
Alex: That is useful prediction evidence, but it is not evidence that an alert prevents an injury. Does the review make that distinction?
Sam: It presents these findings as support for identifying risk and informing earlier intervention. This reported study does not establish that using alerts reduces falls. And the specific example used a chest-worn sensor during a walking test, not unrestricted monitoring through someone’s phone at home.
Alex: So the home-use ambition is broader than the demonstrated setting. What changes when the task is reading an image instead?
Sam: Now the comparison is often with an expert’s assessment. After fracture surgery, clinicians measure features on radiographs to assess the repair. Manual work can be slow and subjective, especially with varied injuries and fixation devices.
Alex: When people say AI reads an image, they can mean several different things. Which matters here?
Sam: Classification assigns a category, such as identifying an implant type. Segmentation identifies the pixels belonging to an object, such as a bone. The distinction matters because a category alone cannot give you the shape needed for a measurement.
Alex: So automated measurement is not necessarily a model producing a number directly. How does the example in this review work?
Sam: Researchers trained models to outline hip bones and the nails used to stabilize fractures near the hip. Conventional image-processing algorithms then located features on those outlines and calculated postoperative measurements. One was tip-apex distance, which locates the implant tip relative to the apex of the femoral head.
Alex: That separates finding the anatomy from measuring it. How did those measurements compare with the human reference?
Sam: The review reports good to excellent agreement with human experts across the measurements studied. The automated approach was fifty times faster. That supports potential use in follow-up assessment and large research cohorts.
Alex: Faster measurement could save work, but agreement on study images is not the same as working everywhere. Is that the central limitation?
Sam: Yes. The review explicitly calls for external validation: testing beyond the data and setting used to develop a model. Trauma images are heterogeneous because injuries and implants vary. Collaboration across institutions is therefore part of establishing whether these tools generalize.
Alex: The last application moves away from patient images toward virtual trials. What does AI add to existing computer simulations?
Sam: Traditional physics-based models can explain how tissues or implants respond to loads. But detailed simulations can be too costly to run for rapid clinical decisions or large studies. The proposed bridge is a surrogate model—a cheaper model trained to approximate those expensive simulations.
Alex: Where do the training examples come from if the patients are virtual?
Sam: Researchers construct a virtual patient cohort that captures variation found in an actual population. They run detailed simulations across that cohort, then use the results to train the surrogate. The surrogate can predict outcomes without repeating the full physics calculation.
Alex: What is a concrete example of the kind of outcome it could predict?
Sam: The review describes a tool called gait-to-contact. It maps movement and force information to predictions of contact mechanics—how surfaces press against each other. Initially developed for implants, it can predict patterns such as wear or accumulated contact pressure.
Alex: But if the model learns from simulations, its predictions still depend on those simulations. How far do the authors take the clinical claim?
Sam: They describe potential decision support and, with appropriate validation, in silico clinical trials: computer-based trials using virtual patients. These could screen interventions or test extreme conditions without exposing patients. The authors explicitly position them as supplements to randomized clinical trials, not replacements.
Alex: Across all these examples, validation sounds like an organizational problem as well as a technical one. Is the association building infrastructure for that?
Sam: Its AI Task Force has produced a position statement emphasizing human oversight, data stewardship, equity, and transparency. It is also developing academic and industry playgrounds for exploring models. But securing external validation before wider access remains a hurdle.
Alex: And shared data would help that effort. Has creating a data resource proved straightforward?
Sam: No. Rather than build its own warehouse, the task force proposed using the existing National Trauma Research Repository. Investigators raised concerns about data ownership, transfer burdens, and complexity. The review describes ongoing work to resolve those barriers, not a completed system.
Alex: Given that mix of working examples and unfinished infrastructure, who should read the full document, and where should they start?
Sam: Researchers planning clinical AI projects should start with “Strategies for tackling orthopaedic problems using AI,” then read their relevant application section. For automated imaging, focus on the comparison with human measurements and the call for external validation. For virtual trials, examine how simulation outputs become surrogate-model training data.
Alex: And for someone deciding whether to adopt these tools, rather than build them?
Sam: Read the task force section for the implementation barriers and oversight principles. My judgment is that this is a useful research map, not proof that the tools improve routine care. For everyone else, remember: a model that performs well in research still has to earn its place in the clinic.
Alex: Thanks for listening.